POP ICON CLAIMS WEIGHT-LOSS SHOTS LINKED TO BLURRY VISION, URGES PUBLIC TO “DO THEIR RESEARCH”
Robbie Williams, the British pop star behind hits like “Angels,” has revealed he believes injectable weight-loss treatments may be impairing his vision. While acknowledging the benefits to his mental health and weight, he reports increasing blurriness and difficulty seeing fans — and is warning others to investigate risks. Current research shows rare eye conditions may be associated with some of the medications, though causation remains unproven.
Robbie Williams has disclosed that his vision has deteriorated while using weight-loss injections and he believes the treatments may be responsible. The 51-year-old singer said he can no longer clearly pick out faces in the crowd at his concerts and that players on a football pitch looked like “blobs on a green field.
Williams explained that he turned to the injectable medications—such as those in the GLP-1/tirzepatide class—for both physical and mental health reasons, saying the treatments had been “liberating” in terms of his self-image and body-dysmorphia struggles.
However, he says he now worries about his eyesight and is urging fans and users of similar treatments to research potential vision risks. He stated: “I was quite an early adopter of the jabs, but what I’m also noticing is that my eyesight’s not very good … I don’t believe it’s age; I believe it’s the jabs.”
Scientific studies confirm that some patients using certain weight-loss medications—especially those originally developed for type 2 diabetes—have shown increased rates of eye conditions including non-arteritic anterior ischemic optic neuropathy (NAION), a rare condition linked with sudden vision loss. But experts emphasise that these findings are signals, not definitive cause-and-effect.
Health professionals stress the importance of monitoring any sudden changes in vision—blurriness, dark spots, flashing lights—and recommend users of such medications consult their doctors and eye specialists. Many underline that while benefits are substantial, awareness of rare but serious side-effects is key.
For Williams, the decision to share his experience marks a meaningful shift from private struggle to public caution. As weight-loss injections grow in popularity worldwide, his warning could resonate with millions navigating weight, wellness and long-term health decisions.
The episode illustrates how treatments once celebrated for rapid results may carry under-examined risks, prompting a broader conversation about transparency, monitoring and informed consent in medical decisions. As Williams continues his career and public life, his vision concerns may become part of a larger debate about the balance between benefits and risks in modern medicine.
